Patients across Peoria, Glendale, Phoenix, Surprise, Goodyear, and the West Valley trust us because we deliver results with compassion, expertise, and medical excellence
10.1038/s41420-022-01199-8 196 OlivierA
Semaglutide-treated patients showed significantly greater reductions in ASMI, handgrip strength and gait speed compared to controls (see Table 2)
In a phase 2 randomised controlled trial published in the New England Journal of Medicine (Jastreboff et al., 2023), participants receiving the highest doses of retatrutide achieved a mean weight reduction of approximately 1724% of body weight over 48 weeks, depending on dose
The gut hormones PYY 336 and GLP-1 736 amide reduce food intake and modulate brain activity in appetite centers in humans